<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5007553 Figure_1-B</id>
    <infon key="sourcedata_document">2003</infon>
    <infon key="doi">10.15252/embj.201593148</infon>
    <infon key="pmc_id">5007553</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Levels of INPP5Eprotein 72 h after transfection of N1E-115 cells with control (siControl) or INPP5E-specific siRNAs (siINPP5E #1 or #2), as determined by immunoblot.</text>
    </passage>
  </document>
  <document>
    <id>5007553 Figure_1-C</id>
    <infon key="sourcedata_document">2003</infon>
    <infon key="doi">10.15252/embj.201593148</infon>
    <infon key="pmc_id">5007553</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C N1E-115 cells treated with siControl or siINPP5Es were cultured for 2 h in growth medium with or without 125 nM bafilomycin A1 (Baf.A1), and then analyzed by immunoblot using anti-p62, anti-LC3, and anti-GAPDH antibodies.</text>
    </passage>
  </document>
  <document>
    <id>5007553 Figure_1-E</id>
    <infon key="sourcedata_document">2003</infon>
    <infon key="doi">10.15252/embj.201593148</infon>
    <infon key="pmc_id">5007553</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>E N1E-115 cells treated with siControl or siINPP5Es were cultured in growth medium. Cells were fixed and stained with anti-LC3 antibodies and analyzed by immunofluorescencemicroscopy. Bar, 10 &#181;m.</text>
    </passage>
  </document>
  <document>
    <id>5007553 Figure_1-G</id>
    <infon key="sourcedata_document">2003</infon>
    <infon key="doi">10.15252/embj.201593148</infon>
    <infon key="pmc_id">5007553</infon>
    <infon key="figure">Figure 1-G</infon>
    <infon key="sourcedata_figure_dir">Figure_1-G</infon>
    <passage>
      <offset>0</offset>
      <text>G Electron micrographs in N1E-115 cells treated with siControl or siINPP5Es were cultured in growth medium. Arrowheads indicate autophagosomes. Bar, 1 &#181;m.</text>
    </passage>
  </document>
  <document>
    <id>5007553 Figure_2-A</id>
    <infon key="sourcedata_document">2003</infon>
    <infon key="doi">10.15252/embj.201593148</infon>
    <infon key="pmc_id">5007553</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A N1E-115 cells treated with siControl, siINPP5E, or siAtg2a/2b were cultured in growth medium. The post-nuclear fraction (PNS) was separated into LSP, HSP, and HSS fractions, and then analyzed by immunoblots using anti-p62, anti-LC3, and GAPDH antibodies. The subfractions were treated with proteinase K (Pro. K) with or without Triton X-100. Quantitation of protein signal intensities from immunoblots showing LC3-II (left) or p62 (right) levels, following normalization to the control protein GAPDH. **, P &lt; 0.01; *, P &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>5007553 Figure_2-B</id>
    <infon key="sourcedata_document">2003</infon>
    <infon key="doi">10.15252/embj.201593148</infon>
    <infon key="pmc_id">5007553</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B NIE-115 cells stably expressing LAMP1-mCherry treated with siControl or siINPP5Es were cultured for 2 h in growth medium containing 200 nM Torin1 with protease inhibitors (10 &#181;g/ml Pepstatin A and 10 &#181;g/ml E-64-d). Because the treatment of protease inhibitors inhibits lysosomal degradation, LC3puncta persist even ifautophagosomes fuse with lysosomes. Cells were fixed and stained with anti-LC3 antibodies, and then analyzed by immunofluorescencemicroscopy. Insets show the boxed areas at high magnification. Bar, 10 &#181;m. C Percentages of colocalization of LC3 dots with LAMP1 dots (mean &#177; s.d.; n &gt; 20 cells from three independent experiments). **, P &lt; 0.01.</text>
    </passage>
  </document>
  <document>
    <id>5007553 Figure_3-B-C</id>
    <infon key="sourcedata_document">2003</infon>
    <infon key="doi">10.15252/embj.201593148</infon>
    <infon key="pmc_id">5007553</infon>
    <infon key="figure">Figure 3-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B N1E-115 cells stably expressing mSt-INPP5E (WT, D477N, &#8710;CAAX, or 295-644) treated with siControl or siINPP5E were cultured in growth medium with or without 125 nM Baf.A1 for 2 h, and then analyzed by immunoblot using anti-LC3 and anti-GAPDH antibodies. The mSt-INPP5Es used in this study were resistant to mouse siINPP5E because target sequence of the siRNA is different from the human correspondent sequence. C Quantitation of protein signal intensities from immunoblots in B, showing differences in LC3-II levels in the presence and absence of Baf.A1 following normalization to the control proteinGAPDH. Results represent means &#177; s.d. of three independent experiments. **, P &lt; 0.01; *, P &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>5007553 Figure_3-D</id>
    <infon key="sourcedata_document">2003</infon>
    <infon key="doi">10.15252/embj.201593148</infon>
    <infon key="pmc_id">5007553</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>D NIE-115 cells stably expressing mSt-INPP5E (WT, D477N, or &#916;CAAX) were cultured in growth medium. Cells were fixed and stained with anti-LAMP1 antibodies, and then analyzed by immunofluorescence microscopy. Insets show the boxed areas at high magnification. The number showing to the right side indicates the colocalization rate of LAMP1 with mSt-INPP5E. Bar, 10 &#181;m.</text>
    </passage>
  </document>
  <document>
    <id>5007553 Figure_4-A-B</id>
    <infon key="sourcedata_document">2003</infon>
    <infon key="doi">10.15252/embj.201593148</infon>
    <infon key="pmc_id">5007553</infon>
    <infon key="figure">Figure 4-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A N1E-115 cells treated with siControl or siINPP5Es were cultured in growth medium with 20 &#181;g/ml DQ-BSA for 12 h and chased for 2 h. Cells were fixed and stained with anti-LAMP1 antibodies and analyzed by immunofluorescencemicroscopy. Insets show the boxed areas at high magnification. Bar, 10 &#181;m. B Quantitation of signal intensities in A showing colocalization of DQ-BSA with LAMP1 (means &#177; s.d.; n &gt; 50 cells from three independent experiments). Baf.A1 was used as a control for inhibition of delivery and degradation of DQ-BSA via the endocytic pathway. **, P &lt; 0.01; n.s., non significant.</text>
    </passage>
  </document>
  <document>
    <id>5007553 Figure_4-C-D</id>
    <infon key="sourcedata_document">2003</infon>
    <infon key="doi">10.15252/embj.201593148</infon>
    <infon key="pmc_id">5007553</infon>
    <infon key="figure">Figure 4-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C N1E-115 cells treated with siControl, siINPP5Es, or siCHMP5 were stimulated with 100 ng/ml EGF for the indicated time periods, and then analyzed by immunoblot using anti-EGFR and anti-&#945;-tubulin antibodies. Levels of CHMP5 mRNA72 h after transfection of N1E-115 cells with siControl or siCHMP5, as analyzed by RT-PCR. D Quantitation of EGFR degradation ratio in C. Results represent means &#177; s.d. of three independent experiments. **, P &lt; 0.01.</text>
    </passage>
  </document>
  <document>
    <id>5007553 Figure_5-A</id>
    <infon key="sourcedata_document">2003</infon>
    <infon key="doi">10.15252/embj.201593148</infon>
    <infon key="pmc_id">5007553</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A NIE-115 cells stably expressing mSt-2xML1N or -2xPLC&#948;1PH were cultured in growth medium with or without 200 nM Torin1. Cells were fixed and stained with anti-LAMP1 or anti-LC3 antibodies, and then analyzed by immunofluorescencemicroscopy. Insets show the boxed areas at high magnification. Bar, 10 &#181;m.</text>
    </passage>
  </document>
  <document>
    <id>5007553 Figure_5-B</id>
    <infon key="sourcedata_document">2003</infon>
    <infon key="doi">10.15252/embj.201593148</infon>
    <infon key="pmc_id">5007553</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B NIE-115 cells stably expressing mSt-2xML1N treated with siControl or siINPP5Es were cultured in growth medium. Cells were fixed and stained with anti-LAMP1 antibodies, and then analyzed by immunofluorescencemicroscopy. Insets show the boxed areas at high magnification. Bar, 10 &#181;m.</text>
    </passage>
  </document>
  <document>
    <id>5007553 Figure_5-D</id>
    <infon key="sourcedata_document">2003</infon>
    <infon key="doi">10.15252/embj.201593148</infon>
    <infon key="pmc_id">5007553</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D N1E-115 cells stably expressing GFP-2xML1N treated with siControl or siINPP5E were transiently transfected with mSt-INPP5E (WT, D477N). Quantitation of signal intensities showing GFP-2xML1N colocalizing with LAMP1 (means &#177; s.d.; n &gt; 20 cells from three independent experiments). **, P &lt; 0.01; *, P &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>5007553 Figure_5-E-F</id>
    <infon key="sourcedata_document">2003</infon>
    <infon key="doi">10.15252/embj.201593148</infon>
    <infon key="pmc_id">5007553</infon>
    <infon key="figure">Figure 5-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E NIE-115 cells stably expressing mCherry-2xFYVE treated with siControl or siINPP5Es were cultured in growth medium. Cells were fixed and stained with anti-LAMP1 antibodies, and then analyzed by immunofluorescence microscopy. Insets show the boxed areas at high magnification. Bar, 10 &#181;m. F Quantitation of signal intensities in E showing mCherry-2xFYVE colocalizing with LAMP1 (means &#177; s.d.; n &gt; 100 cells from three independent experiments). **, P &lt; 0.01.</text>
    </passage>
  </document>
  <document>
    <id>5007553 Figure_6-A</id>
    <infon key="sourcedata_document">2003</infon>
    <infon key="doi">10.15252/embj.201593148</infon>
    <infon key="pmc_id">5007553</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A N1E-115 cells treated with siControl or siINPP5Es were cultured in growth medium. Cells were fixed and stained with anti-LAMP1 antibodies and Phalloidin, and then analyzed by immunofluorescencemicroscopy. Insets show the boxed areas at high magnification. Bar, 10 &#181;m. Quantitation of signal intensities showing Phalloidin colocalizing with LAMP1 (means &#177; s.d.; n &gt; 40 cells from three independent experiments). **, P &lt; 0.01.</text>
    </passage>
  </document>
  <document>
    <id>5007553 Figure_6-B</id>
    <infon key="sourcedata_document">2003</infon>
    <infon key="doi">10.15252/embj.201593148</infon>
    <infon key="pmc_id">5007553</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>B N1E-115 cells treated with siControl or siINPP5Es were cultured in growth medium. Cells were fixed and stained with anti-phospho-Y421 cortactin and anti-LAMP1 antibodies, and then analyzed by immunofluorescencemicroscopy. Insets show the boxed areas at high magnification. Bar, 10 &#181;m. Quantitation of signal intensities showing cortactin (pY421) colocalizing with LAMP1 (means &#177; s.d.; n &gt; 40 cells from three independent experiments). **, P &lt; 0.01.</text>
    </passage>
  </document>
  <document>
    <id>5007553 Figure_6-C</id>
    <infon key="sourcedata_document">2003</infon>
    <infon key="doi">10.15252/embj.201593148</infon>
    <infon key="pmc_id">5007553</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>C N1E-115 cells were treated with 0.5 &#181;M Latrunculin A (Lat A) in growth medium for 6 h. Cells were fixed and stained with anti-LC3 antibodies, and then analyzed by immunofluorescencemicroscopy. Bar, 10 &#181;m. Quantitation of the number of LC3puncta per cell. (mean &#177; s.d.; n &gt; 100 cells from three independent experiments). **, P &lt; 0.01.</text>
    </passage>
  </document>
  <document>
    <id>5007553 Figure_6-D</id>
    <infon key="sourcedata_document">2003</infon>
    <infon key="doi">10.15252/embj.201593148</infon>
    <infon key="pmc_id">5007553</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>D NIE-115 cells stably expressing LAMP1-mCherry were treated with DMSO or 0.5 &#181;M Lat A in growth medium for 4 h, subsequently cultured with 200 nM Torin1 and protease inhibitors (10 &#181;g/ml Pepstatin A and 10 &#181;g/ml E-64-d) for 2 h (Lat A treatment for total 6h). Cells were fixed and stained with anti-LC3 antibodies, and then analyzed by immunofluorescencemicroscopy. Insets show the boxed areas at high magnification. Bar, 10 &#181;m. Percentages of colocalization of LC3 dots with LAMP1 dots (mean &#177; s.d.; n &gt; 20 cells from three independent experiments). **, P &lt; 0.01.</text>
    </passage>
  </document>
  <document>
    <id>5007553 Figure_7-B-C</id>
    <infon key="sourcedata_document">2003</infon>
    <infon key="doi">10.15252/embj.201593148</infon>
    <infon key="pmc_id">5007553</infon>
    <infon key="figure">Figure 7-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B N1E-115 cells stably expressing the indicated mutants treated with siControl or siINPP5E were cultured in growth medium with or without 125 nM Baf.A1 for 2 h, and analyzed by immunoblot using anti-LC3 and anti-GAPDH antibodies. The mutants were resistant to mouse siINPP5E because target sequence of the siRNA is different from the human correspondent sequence. C Quantitation of protein signal intensities from immunoblots in B showing differences in LC3-II levels in the presence and absence of Baf.A1 following normalization to the control proteinGAPDH. Results represent means &#177; s.d. of three independent experiments. **, P &lt; 0.01; *, P &lt; 0.05.</text>
    </passage>
  </document>
</collection>
